246 related articles for article (PubMed ID: 25065264)
1. Activation of TLR9-dependent p38MAPK pathway in the pathogenesis of primary Sjögren's syndrome in NOD/Ltj mouse.
Shi H; Yu CQ; Xie LS; Wang ZJ; Zhang P; Zheng LY
J Oral Pathol Med; 2014 Nov; 43(10):785-91. PubMed ID: 25065264
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the TLR9-dependent p38 MAPK signaling pathway improves the pathogenesis of primary Sjögren's syndrome in the NOD/Ltj mouse.
Cao N; Shi H; Chen C; Zheng L; Yu C
J Biol Regul Homeost Agents; 2021; 35(3):1103-1108. PubMed ID: 34034463
[No Abstract] [Full Text] [Related]
3. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
4. Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy.
Soyfoo MS; De Vriese C; Debaix H; Martin-Martinez MD; Mathieu C; Devuyst O; Steinfeld SD; Delporte C
Arthritis Rheum; 2007 Aug; 56(8):2566-74. PubMed ID: 17665453
[TBL] [Abstract][Full Text] [Related]
5. NOD mouse model for Sjögren's syndrome: lack of longitudinal stability.
Lodde BM; Mineshiba F; Kok MR; Wang J; Zheng C; Schmidt M; Cotrim AP; Kriete M; Tak PP; Baum BJ
Oral Dis; 2006 Nov; 12(6):566-72. PubMed ID: 17054769
[TBL] [Abstract][Full Text] [Related]
6. Non-proliferating plasma cells detected in the salivary glands and bone marrow of autoimmune NOD.B10.H2b mice, a model for primary Sjögren's syndrome.
Szyszko EA; Aqrawi LA; Jonsson R; Brokstad KA; Skarstein K
Autoimmunity; 2016; 49(1):41-9. PubMed ID: 26324998
[TBL] [Abstract][Full Text] [Related]
7. P2Y2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjögren's syndrome.
Schrader AM; Camden JM; Weisman GA
Arch Oral Biol; 2005 Jun; 50(6):533-40. PubMed ID: 15848146
[TBL] [Abstract][Full Text] [Related]
8. B7-H4 Inhibits the Development of Primary Sjögren's Syndrome by Regulating Treg Differentiation in NOD/Ltj Mice.
Zheng X; Wang Q; Yuan X; Zhou Y; Chu H; Wang G; Li X; Wang Y; Wei L; Wang L; Li X
J Immunol Res; 2020; 2020():4896727. PubMed ID: 33062721
[TBL] [Abstract][Full Text] [Related]
9. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB
J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-17 Impairs Salivary Tight Junction Integrity in Sjögren's Syndrome.
Zhang LW; Cong X; Zhang Y; Wei T; Su YC; Serrão AC; Brito AR; Yu GY; Hua H; Wu LL
J Dent Res; 2016 Jul; 95(7):784-92. PubMed ID: 26933138
[TBL] [Abstract][Full Text] [Related]
11. Expression of Toll-like receptors 7, 8, and 9 in primary Sjögren's syndrome.
Zheng L; Zhang Z; Yu C; Yang C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jun; 109(6):844-50. PubMed ID: 20399690
[TBL] [Abstract][Full Text] [Related]
12. Huoxue Jiedu Recipe represses mitochondrial fission to alleviate submandibular gland inflammation in Sjögren's syndrome.
Xu J; Shen Z; Du Y; Zhang S; Xi Y; Zhang Y; Wang D; Zhu Y
Microbiol Immunol; 2023 Aug; 67(8):377-387. PubMed ID: 37340676
[TBL] [Abstract][Full Text] [Related]
13. Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndrome.
Yamachika S; Nanni JM; Nguyen KH; Garces L; Lowry JM; Robinson CP; Brayer J; Oxford GE; da Silveira A; Kerr M; Peck AB; Humphreys-Beher MG
J Rheumatol; 1998 Dec; 25(12):2371-80. PubMed ID: 9858432
[TBL] [Abstract][Full Text] [Related]
14. Effects of total glucosides of paeony for delaying onset of Sjogren's syndrome: an animal study.
Li CL; He J; Li ZG; Zheng LW; Hua H
J Craniomaxillofac Surg; 2013 Oct; 41(7):610-5. PubMed ID: 23333492
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 9 signaling promotes autophagy and apoptosis via divergent functions of the p38/JNK pathway in human salivary gland cells.
Fu J; Shi H; Cao N; Wu S; Zhan T; Xie L; Wang Z; Ye L; Li C; Shen Y; Yu C; Zheng L
Exp Cell Res; 2019 Feb; 375(2):51-59. PubMed ID: 30610847
[TBL] [Abstract][Full Text] [Related]
16. Role of complement and B lymphocytes in Sjögren's syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice.
Nguyen C; Cornelius J; Singson E; Killedar S; Cha S; Peck AB
Mol Immunol; 2006 Mar; 43(9):1332-9. PubMed ID: 16221495
[TBL] [Abstract][Full Text] [Related]
17. Activation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome.
Gilboa-Geffen A; Wolf Y; Hanin G; Melamed-Book N; Pick M; Bennett ER; Greenberg DS; Lester S; Rischmueller M; Soreq H
PLoS One; 2011; 6(12):e28727. PubMed ID: 22174879
[TBL] [Abstract][Full Text] [Related]
18. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland.
Jonsson MV; Delaleu N; Brokstad KA; Berggreen E; Skarstein K
Arthritis Rheum; 2006 Jul; 54(7):2300-5. PubMed ID: 16802370
[TBL] [Abstract][Full Text] [Related]
19. Fangchinoline Inhibited Proliferation of Neoplastic B-lymphoid Cells and Alleviated Sjögren's Syndrome-like Responses in NOD/Ltj Mice via the Akt/mTOR Pathway.
Shao Y; Fu J; Zhan T; Ye L; Yu C
Curr Mol Pharmacol; 2022; 15(7):969-979. PubMed ID: 35176991
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice.
Park E; Kim D; Lee SM; Jun HS
Oncotarget; 2017 Apr; 8(16):27240-27251. PubMed ID: 28460477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
